Abbott Laboratories banner

Abbott Laboratories
LSE:0Q15

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
LSE:0Q15
Watchlist
Price: 87.98 USD -1.99% Market Closed
Market Cap: $154.1B

Intrinsic Value

0Q15 price has not been updated for more than 4 years. This may indicate that the stock has been delisted.

The intrinsic value for Abbott Laboratories (0Q15) under the Base Case is 114.8 USD. Compared with the current market price of 87.98 USD, the stock appears Undervalued by 23% .

Based on two methods:

Both DCF and multiples point to undervaluation.

0Q15 Intrinsic Value
114.8 USD
Undervaluation 23%
Intrinsic Value
Price $87.98
Bear Case
Base Case
Bull Case
Monitor 0Q15
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $91.84
Get notified when the price drops into your buy zone
Intrinsic Value $114.8
Margin of Safety 20% $91.84
Current Price $87.98
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about 0Q15?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0Q15 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Abbott Laboratories.

Explain Valuation
Alternatives to 0Q15

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

ABT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 0Q15 stock?

The intrinsic value for Abbott Laboratories (0Q15) under the Base Case is 114.8 USD.

Is 0Q15 stock undervalued or overvalued?

Compared with the current market price of 87.98 USD, the stock appears Undervalued by 23% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett